Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.
As of close of business last night, Aspen Aerogels Inc’s stock clocked out at $8.31, down -5.78% from its previous closing price of $8.82. In other words, the price has decreased by -$5.78 from its previous closing price. On the day, 3.07 million shares were traded. ASPN stock price reached its highest trading level at $9.348 during the session, while it also had its lowest trading level at $8.26.
Ratios:
To gain a deeper understanding of ASPN’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.31 and its Current Ratio is at 3.98. In the meantime, Its Debt-to-Equity ratio is 0.56 whereas as Long-Term Debt/Eq ratio is at 0.45.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Aug 12 ’25 when Daniel Santhosh P sold 4,410 shares for $7.31 per share. The transaction valued at 32,237 led to the insider holds 19,879 shares of the business.
Daniel Santhosh P sold 2,000 shares of ASPN for $15,080 on Aug 13 ’25. The Chief Accounting Officer now owns 17,879 shares after completing the transaction at $7.54 per share. On Aug 12 ’25, another insider, SANTHOSH P DANIEL, who serves as the Officer of the company, bought 4,410 shares for $7.31 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ASPN now has a Market Capitalization of 684415680 and an Enterprise Value of 689965696. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.72 while its Price-to-Book (P/B) ratio in mrq is 2.21. Its current Enterprise Value per Revenue stands at 1.737 whereas that against EBITDA is 13.002.
Stock Price History:
The Beta on a monthly basis for ASPN is 2.81, which has changed by -0.61527777 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, ASPN has reached a high of $26.90, while it has fallen to a 52-week low of $4.16. The 50-Day Moving Average of the stock is 15.43%, while the 200-Day Moving Average is calculated to be 10.27%.
Shares Statistics:
It appears that ASPN traded 2.12M shares on average per day over the past three months and 2582540 shares per day over the past ten days. A total of 82.25M shares are outstanding, with a floating share count of 80.98M. Insiders hold about 1.67% of the company’s shares, while institutions hold 87.27% stake in the company. Shares short for ASPN as of 1759190400 were 10285318 with a Short Ratio of 4.86, compared to 1756425600 on 9301272. Therefore, it implies a Short% of Shares Outstanding of 10285318 and a Short% of Float of 14.92.
Earnings Estimates
At present, 4.0 analysts are actively evaluating the performance of Aspen Aerogels Inc (ASPN) in the stock market.The consensus estimate for the next quarter is $0.01, with high estimates of $0.03 and low estimates of -$0.02.
Analysts are recommending an EPS of between -$0.06 and -$0.23 for the fiscal current year, implying an average EPS of -$0.14. EPS for the following year is $0.2, with 3.0 analysts recommending between $0.43 and $0.02.
Revenue Estimates
In. The current quarter, 7 analysts expect revenue to total $73.42M. It ranges from a high estimate of $77.6M to a low estimate of $70.2M. As of. The current estimate, Aspen Aerogels Inc’s year-ago sales were $117.34MFor the next quarter, 7 analysts are estimating revenue of $73.51M. There is a high estimate of $80M for the next quarter, whereas the lowest estimate is $70.5M.
A total of 7 analysts have provided revenue estimates for ASPN’s current fiscal year. The highest revenue estimate was $306.9M, while the lowest revenue estimate was $299.93M, resulting in an average revenue estimate of $303.66M. In the same quarter a year ago, actual revenue was $452.7MBased on 7 analysts’ estimates, the company’s revenue will be $325.02M in the next fiscal year. The high estimate is $350.9M and the low estimate is $290.1M.
